Department of Surgery, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa, Kanagawa, Japan.
Surg Today. 2023 Jun;53(6):728-735. doi: 10.1007/s00595-022-02631-3. Epub 2022 Dec 11.
The World Health Organization recommends prophylactic negative pressure wound therapy (NPWT) for high-risk SSI wounds, despite which delayed wound healing (DWH) remains a problem. The aim of this study was to define the risk factors for DWH under prophylactic NPWT following colorectal perforation (CP).
The subjects of this retrospective study were patients who underwent emergency laparotomy and prophylactic NPWT for CP between 2011 and 2019 at Fujisawa City Hospital in Japan. Multivariable analysis was performed to identify which perioperative factors impact DWH.
A total of 58 patients met the inclusion criteria and the median period from surgery to wound closure was 12 days (IQR: 8-18). Most factors, including preoperative steroid use, diabetes, and serum albumin, were not associated with DWH, although patients requiring catecholamine were more likely to have DWH (OR 7.81, 95% CI 1.55-39.24, p = 0.013). The median in-hospital cost was more than double for patients with DWH vs. those without DWH (41.36 kUSD [IQR 24.95-51.89] vs. 20.32 kUSD [IQR 16.69-28.45], p < 0.001).
Catecholamine use was a greater risk factor for DWH than previously reported factors such as diabetes and the serum albumin level. Further study is needed to investigate strategies to prevent DWH and optimize the utilization of NPWT, especially in patients requiring catecholamine.
世界卫生组织建议对高风险手术部位感染(SSI)伤口预防性使用负压伤口治疗(NPWT),但仍存在伤口愈合延迟(DWH)的问题。本研究旨在明确结直肠穿孔(CP)后预防性 NPWT 下发生 DWH 的危险因素。
本回顾性研究对象为 2011 年至 2019 年期间在日本藤泽市医院因 CP 接受急诊剖腹术和预防性 NPWT 的患者。采用多变量分析确定影响 DWH 的围手术期因素。
共纳入 58 例患者,手术至伤口闭合的中位时间为 12 天(IQR:8-18)。尽管术前使用类固醇、糖尿病和血清白蛋白等大多数因素与 DWH 无关,但需要儿茶酚胺的患者更有可能发生 DWH(OR 7.81,95%CI 1.55-39.24,p=0.013)。与无 DWH 的患者相比,DWH 患者的住院费用中位数高出一倍以上(41.36 千美元 [IQR 24.95-51.89] 比 20.32 千美元 [IQR 16.69-28.45],p<0.001)。
与糖尿病和血清白蛋白水平等先前报道的因素相比,儿茶酚胺的使用是 DWH 的更大危险因素。需要进一步研究以探讨预防 DWH 和优化 NPWT 利用的策略,特别是在需要儿茶酚胺的患者中。